The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104229142 10422914 2 F 20140407 20160912 20140902 20160921 EXP US-009507513-1408USA016093 MERCK 67.00 YR F Y 113.40000 KG 20160921 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104229142 10422914 1 PS PRINIVIL LISINOPRIL 1 Oral 20 MG, BID Y 19558 20 MG TABLET BID
104229142 10422914 2 SS CELECOXIB. CELECOXIB 1 Oral UNK Y 0
104229142 10422914 3 SS CELECOXIB. CELECOXIB 1 Y 0
104229142 10422914 4 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 UNK U 0
104229142 10422914 5 C LEVOTHYROXINE SODIUM. LEVOTHYROXINE SODIUM 1 UNK U 0 TABLET
104229142 10422914 6 C OXYBUTYNIN OXYBUTYNIN 1 UNK U 0
104229142 10422914 7 C PRAVASTATIN SODIUM. PRAVASTATIN SODIUM 1 UNK U 0
104229142 10422914 8 C ASPIRIN. ASPIRIN 1 UNK U 0
104229142 10422914 9 C XANAX ALPRAZOLAM 1 UNK U 0
104229142 10422914 10 C CYCLOBENZAPRINE HYDROCHLORIDE. CYCLOBENZAPRINE HYDROCHLORIDE 1 UNK U 0
104229142 10422914 11 C RANITIDINE. RANITIDINE 1 UNK U 0
104229142 10422914 12 C DOCUSATE SODIUM. DOCUSATE SODIUM 1 UNK U 0
104229142 10422914 13 C VENLAFAXINE HYDROCHLORIDE. VENLAFAXINE HYDROCHLORIDE 1 UNK U 0
104229142 10422914 14 C METOPROLOL. METOPROLOL 1 UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104229142 10422914 1 Hypertension
104229142 10422914 2 Osteoarthritis
104229142 10422914 3 Rheumatoid arthritis
104229142 10422914 4 Gastritis prophylaxis
104229142 10422914 5 Hypothyroidism
104229142 10422914 6 Incontinence
104229142 10422914 7 Blood cholesterol increased
104229142 10422914 8 Cardiovascular event prophylaxis
104229142 10422914 9 Anxiety
104229142 10422914 10 Temporomandibular joint syndrome
104229142 10422914 11 Gastrooesophageal reflux disease
104229142 10422914 12 Constipation
104229142 10422914 13 Depression
104229142 10422914 14 Hypertension

Outcome of event

Event ID CASEID OUTC COD
104229142 10422914 HO
104229142 10422914 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
104229142 10422914 Anaphylactic reaction

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104229142 10422914 1 2010 20140407 0
104229142 10422914 2 20130504 20130903 0
104229142 10422914 4 20130503 20130903 0
104229142 10422914 5 2013 0
104229142 10422914 6 2003 0
104229142 10422914 7 1998 0
104229142 10422914 8 1998 0
104229142 10422914 9 2003 0
104229142 10422914 10 2006 0
104229142 10422914 11 201309 0
104229142 10422914 12 201307 0
104229142 10422914 13 20131103 0
104229142 10422914 14 201312 0